Charles B. Nemeroff, M.D., Ph.D.

Original Research

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

November 26, 2013

Commentary

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

October 15, 2013

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

Article

Prevalence and Management of Treatment-Resistant Depression

July 16, 2007

Article

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

February 15, 2006

Article

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

November 15, 2005

Article

Introduction.

November 15, 2005

Original Research

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

October 14, 2005

Article

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

August 15, 2005

Article

Introduction. Developmental Neurobiology and Psychiatry: Challenges and Best Practices for Studies in Children and Adolescents

August 15, 2005

Original Research

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

January 15, 2005